A well performing medial fixed bearing UKA with promising survivorship at 15 years

Arch Orthop Trauma Surg. 2023 May;143(5):2693-2699. doi: 10.1007/s00402-022-04562-7. Epub 2022 Jul 30.

Abstract

Background: Unicompartmental knee arthroplasty (UKA) accounts for 10% of knee arthroplasty procedures in Europe. Fixed bearing UKA designs have shown favorable survivorship in registries when compared with mobile bearings. This study analyses long-term follow-up of patients with a medial fixed bearing metal backed tibial UKA and reports 15 years survivorship and clinical outcomes.

Methods: Data were collected prospectively for 148 medial unicompartmental fixed bearing metal backed UKAs implanted in 148 patients in two high volumes knee arthroplasty centers between January 2005 and December 2007. The indication was osteoarthritis in all but 2 patients. Patients' reported outcome scores were documented at last follow up. The mean patient age at time of surgery was 65 years.

Results: At final follow up, outcome and survivorship data were collected for 124 medial fixed bearing UKAs. Thirteen patients underwent revision; average time to revision was 77 months (SD 35.31). The Kaplan-Meier analysis demonstrated a survivorship of 97.65% at 69 months and of 89,52%. at 120 months and 173 months of follow-up. When revisions for infection were excluded, the survivorship of the implant was 90.3% at the last of follow up. The mean OKS was 43.02 (SD 5.1) at the last follow-up, and the mean FJS was 77.6 (SD 6.9).

Conclusion: This Medial fixed bearing metal backed UKA demonstrates promising long-term survivorship and patient outcomes. It appears to be a suitable and reasonably lasting option for the treatment of medial compartment OA.

Keywords: Fixed bearing; Long term; Survivorship; Unicompartmental knee arthroplasty.

MeSH terms

  • Aged
  • Arthroplasty, Replacement, Knee* / methods
  • Follow-Up Studies
  • Humans
  • Knee Joint / surgery
  • Knee Prosthesis*
  • Osteoarthritis, Knee* / surgery
  • Reoperation
  • Retrospective Studies
  • Survivorship
  • Treatment Outcome

Substances

  • 3-methyl-N,N-diethyl-p-phenylenediamine